DDX60 selectively reduces translation off viral type II internal ribosome entry sites

Mohammad Sadic1, William M Schneider2, Olga Katsara1

  • 1NYU Grossman School of Medicine, New York, NY, USA.

EMBO Reports
|October 18, 2022
PubMed

Insights

Interferon-stimulated protein DDX60 selectively inhibits viral replication by reducing translation from specific viral RNA structures called type II internal ribosome entry sites (IRESs). This antiviral mechanism targets viral protein synthesis without broadly affecting host cell translation.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Viruses hijack host protein synthesis for replication.
  • Host defense mechanisms often globally inhibit mRNA translation, impacting host cells.
  • Interferon-stimulated genes play a crucial role in antiviral immunity.

Purpose of the Study:

  • To identify and characterize host factors that selectively inhibit viral translation.
  • To investigate the role of the interferon-stimulated helicase DDX60 in antiviral defense.
  • To elucidate the mechanism by which DDX60 restricts viral replication.

Main Methods:

  • Investigated the effect of DDX60 on translation from different types of internal ribosome entry sites (IRESs).
  • Assessed viral replication of encephalomyocarditis virus (EMCV), foot and mouth disease virus (FMDV), poliovirus, and bovine enterovirus 1 (BEV-1) in the presence of DDX60.
  • Analyzed ribosome occupancy on viral IRES and 5' cap-dependent mRNAs.

Main Results:

  • DDX60 selectively inhibits translation from type II IRESs (EMCV, FMDV), but not other IRES types or 5' cap-dependent translation.
  • DDX60 reduces the replication of viruses utilizing type II IRESs (EMCV, FMDV), but not those with type I IRESs (poliovirus, BEV-1).
  • Replacing poliovirus IRES with a type II IRES rendered it sensitive to DDX60 inhibition.
  • DDX60 modulates ribosome loading specifically on type II IRES mRNAs.

Conclusions:

  • DDX60 is an interferon-stimulated gene product that acts as a selective antiviral factor.
  • DDX60 inhibits viral replication by downregulating translation initiated from type II IRES elements.
  • This study reveals a novel mechanism of innate antiviral immunity targeting specific viral RNA structures.

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
34.4K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.2K
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K